• Home
  •  
    Regions
    • Europe
    • UK & Ireland
    • DACH
    • Nordic
    • France
    • Southern Europe
    • Benelux
    • CEE
    • Asia
  •  
    Deals
    • Buyouts
    • Venture
    • Exits
    • Refinancings
    • Build-up
    • Turnaround
    • Secondaries
    • Advanced deals search
  •  
    Funds
    • Buyout
    • Venture
    • Mezzanine
    • Debt
    • Funds-of-funds
    • Secondaries
    • Fundraising pipelines
    • Advanced funds search
  •  
    GPs & LPs
    • GP profiles
    • LP profiles
    • GP news
    • LP news
    • Sponsors search
    • LPs search
  •  
    Secondaries
    • Deals
    • Funds
    • News
    • Analysis
  •  
    People
    • People moves
    • Analysis
    • In Profile
    • Q&A
    • Videos
    • Comment
  •  
    Analysis
    • In Profile
    • Fundraising
    • Q&A
    • Comment
    • Videos
    • Podcast
    • Reports
    • Data Snapshots
  •  
    Unquote Data
    • Deals search
    • Exits search
    • Funds search
    • Sponsors search
    • Advisers search
    • LPs search
    • League tables
    • Reports
  • Sign in
  • Sign in
    • You are currently accessing unquote.com via your Enterprise account.

      If you already have an account please use the link below to sign in.

      If you have any problems with your access or would like to request an individual access account please contact our customer service team.

      Phone: +44 (0)203 741 1137

      Email: Georgina.Lawson@acuris.com

      • Sign in
     
      • Newsletters
      • Account details
      • Contact support
      • Sign out
     
  • Follow us
    • Twitter
    • LinkedIn
  • Free Trial
  • Subscribe
Unquote
Unquote
  • Home
  • Regions
  • Deals
  • Funds
  • GPs & LPs
  • Secondaries
  • People
  • Analysis
  • Unquote Data
  • You are currently accessing unquote.com via your Enterprise account.

    If you already have an account please use the link below to sign in.

    If you have any problems with your access or would like to request an individual access account please contact our customer service team.

    Phone: +44 (0)203 741 1137

    Email: Georgina.Lawson@acuris.com

    • Sign in
 
    • Newsletters
    • Account details
    • Contact support
    • Sign out
 
Unquote
  • Expansion

Oaktree-backed NL Holding buys ProCrea, Archimed, Imer

  • Francesca Veronesi
  • Francesca Veronesi
  • 16 February 2018
  • Tweet  
  • Facebook  
  • LinkedIn  
  • Google plus  
  • Send to  

Oaktree Capital Management-backed German healthcare technology group NL Holding has acquired competitors ProCrea Group, Archimed and the Instituto de Medicina Reproductiva (Imer) to create a pan-European group.

NL Holding was backed by Oaktree in Q4 2017 and announced at the time its objective of expanding internationally.

The MBO of 2017, valued at around €200m, saw Oaktree acquire a minority stake alongside management and private investors, a source close to the deal confirmed. 

ProCrea Group; Archimed; Imer

  • DEAL:

    Portofolio management

  • LOCATION:

    Lugano, Lombardy, Valencia

  • SECTOR:

    Biotechnology

The previous year, management and private investors injected €60-80m in NL Holding, Unquote understands. 

Founded in 2015 by Martin Würtele and originally named Next LL Holding, NL Holding is a group of healthcare technology companies focusing on reproductive medicine, pneumology, allergology and clinical immunology. Its services are currently available in the Czech Republic and Germany. The company is registered in Germany and headquartered in Aystetten.

NL Holding aims to build a European network of clinics that focus on reproductive medicine. More acquisitions are planned for 2018, and an additional €45-60m could be invested in the company later on in the year, a spokesperson for NL Holding disclosed. 

Company
ProCrea, operating in the Italian-speaking region of Switzerland as well as northern Italy, is a diagnostics service and provides vitro fertilisation treatments. The company is based in Lugano.

Archimed is a diagnostic center specialising in genetics, with facilities in northern Italy. It offers laboratory and diagnostic services for 600 healthcare facilities in Italy.

Imer provides diagnostics services and in vitro fertilisation treatments. Based in Spain, the company also manages egg-donation centres that work closely with facilities for assisted reproduction in Italy. The company is headquartered in Valencia and also operates centres in Denia and Barcelona. 

People
NL Holding – Martin Würtele (founder); Miroslaw Herden (CEO); Josef Brož (head of advisory board).
Oaktree Capital Management – Hermann Dambach, Andreas Krämer, (managing directors); Heiko Keppler (senior vice-president).

  • Tweet  
  • Facebook  
  • LinkedIn  
  • Google plus  
  • Send to  
  • Topics
  • Expansion
  • Southern Europe
  • DACH
  • Healthcare
  • Switzerland
  • Italy
  • Spain
  • Oaktree Capital Management
  • Build-up

More on Expansion

Wealth managers and financial advisers
Blackstone takes minority stake in Groupe Premium

Deal values French wealth manager at EUR 1.15bn after earlier full exit attempt saw Eurazeo target EUR 1.5bn

  • Expansion
  • 31 July 2023
Risk and compliance management services
e-Attestations aims to triple size with new Keensight backing

Keensight is investing in the risk management platform via its EUR 1bn fifth fund, which closed in 2019

  • Expansion
  • 25 July 2023
Bolt-ons and buy-and-build platforms
The Bolt-Ons Digest - 3 July 2023

Unquote’s selection of the latest add-ons with Palatine's Anthesis, Nordic Capital's Regnology, Waterland's Janssen and more

  • Expansion
  • 03 July 2023
Valentina Vitali of Limerston Capital
GP Profile: Limerston Capital anticipates higher volume but more complex M&A as market steadies

UK-based GP is seeing dealflow driven by carve-outs and buy-and-build in a market where organic multiple arbitrage is no longer a given

  • GPs
  • 07 June 2023

Latest News

Fund closes in US dollars
  • Funds
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme

Multi-family office has seen strong appetite, with investor base growing since 2016 to more than 90 family offices, Meiping Yap told Unquote

  • 05 September 2023
Clinical trials and biotechnology
  • Buyouts
Permira to take Ergomed private for GBP 703m

Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO

  • 04 September 2023
Public sector software
  • Exits
Partners Group to release IMs for Civica sale in mid-September

Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017

  • 04 September 2023
EMEA Public to Private M&A
  • Investments
Change of mind: Sponsors take to de-listing their own assets

EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater

  • 04 September 2023
Back to Top
  • About Unquote
  • Advertise
  • Contacts
  • About Acuris
  • Terms of Use
  • Privacy Policy
  • Group Disclaimer
  • Twitter
  • LinkedIn

© Merger Market

© Mergermarket Limited, 10 Queen Street Place, London EC4R 1BE - Company registration number 03879547

Digital publisher of the year 2010 & 2013

Digital publisher of the year 2010 & 2013